2023-02-15

Camurus' Full Year Report 2022

Fluidcrystal Injection Depot 1

Camurus' Full Year Report for 2022 was published on February 14. 2022 was the first profitable year for Camurus, driven by strong sales growth.

"We ended the year with a fourth quarter with excellent performance across the organization, strong sales momentum, positive operating results, and continued pipeline progress. Camurus reported full year profitability for the first time while also investing half a billion SEK in our R&D pipeline", says Fredrik Tiberg, President & CEO.

Read the full report on Camurus' website: 

Camurus’ Full Year Report 2022 - Camurus

Latest news

2019-04-10

Camurus’ rights issue oversubscribed

Camurus’ rights issue of 403 MSEK has been oversubscribed. The rights issue was carried out to secure financing of t…

Read more

2019-04-10

Positive results for Buvidal® in treatment for fentanyl dependence

New positive results from a Phase 3 study show that Camurus’ Buvidal® provides better treatment effect for fentanyl…

Read more

2019-04-10

Court proceedings initiated for immediate market approval of Brixadi™ in the US

Camurus’ partner, Braeburn Inc., has initiated court proceedings foran approval of Brixadi (Buvidal® in the US) and…

Read more

2019-02-26

Spin-off of GAIM from Aimpoint

Based on Aimpoint's red dot sight for fire arms, the company has developed a commercial VR platform, GAIM, which is…

Read more

2019-02-08

60 years of driving innovation in Skåne

In 1959, Gunnar Sandberg established ElektroSandberg and lay the foundation for what we now know as Sandberg Develop…

Read more